Edgar Filing: CME GROUP INC.

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2010

- OR -

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-31553

CME GROUP INC.

(Exact name of registrant as specified in its charter)

Delaware

36-4459170

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)


20 South Wacker Drive, Chicago, Illinois		60606
(Address of principal executive offices)		(Zip Code)

(312) 930-1000

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares outstanding of each of the registrant’s classes of common stock as of October 20, 2010 was as follows: 67,011,625 shares of Class A common stock, $0.01 par value; 625 shares of Class B common stock, Class B-1, $0.01 par value; 813 shares of Class B common stock, Class B-2, $0.01 par value; 1,287 shares of Class B common stock, Class B-3, $0.01 par value; and 413 shares of Class B common stock, Class B-4, $0.01 par value.

CME GROUP INC.

FORM 10-Q

INDEX


		Page

PART I. FINANCIAL INFORMATION			3

Item 1.	Financial Statements		6

	Consolidated Balance Sheets at September 30, 2010 and December 31, 2009		6

	Consolidated Statements of Income for the Quarters and Nine Months Ended September 30, 2010 and 2009		7

	Consolidated Statements of Shareholders’ Equity for the Nine Months Ended September 30, 2010 and 2009		8

	Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2010 and 2009		10

	Notes to Unaudited Consolidated Financial Statements		12

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		20

Item 3.	Quantitative and Qualitative Disclosures about Market Risk		28

Item 4.	Controls and Procedures		28

PART II. OTHER INFORMATION			28

Item 1.	Legal Proceedings		28

Item 1A.	Risk Factors		29

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		29

Item 6.	Exhibits		30

SIGNATURES			31

PART I: FINANCIAL INFORMATION

Certain Terms

All references to “options” or “options contracts” in the text of this document refer to options on futures contracts.

Unless otherwise indicated, references to CME Group Inc. (CME Group) products include references to exchange-traded products on one of its regulated exchanges: Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX). Products listed on these exchanges are subject to the rules and regulations of the particular exchange and the applicable rulebook should be consulted. Unless otherwise indicated, references to NYMEX include its subsidiary, COMEX.

Further information about CME Group and its products can be found at http://www.cmegroup.com. Information made available on our Web site does not constitute a part of this Report.

Trademark Information

CME Group is a trademark of CME Group Inc. The Globe logo, CME, Chicago Mercantile Exchange, Globex and E-mini, are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. All other trademarks are the property of their respective owners.

FORWARD-LOOKING STATEMENTS

From time to time, in this Quarterly Report on Form 10-Q as well as in other written reports and verbal statements, we discuss our expectations regarding future performance. These forward-looking statements are identified by their use of terms and phrases such as “believe,” “anticipate,” “could,” “estimate,” “intend,” “may,” “plan,” “expect” and similar expressions, including references to assumptions. These forward-looking statements are based on currently available competitive, financial and economic data, current expectations, estimates, forecasts and projections about the industries in which we operate and management’s beliefs and assumptions. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are:

•

increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities;

•

our ability to keep pace with rapid technological developments, including our ability to complete the development and implementation of the enhanced functionality required by our customers;

•

our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services;

•

our ability to adjust our fixed costs and expenses if our revenues decline;

•

our ability to generate revenues from our processing services;

•

our ability to maintain existing customers, develop strategic relationships and attract new customers;

•

our ability to expand and offer our products in foreign jurisdictions;

•

changes in domestic and foreign regulations;

•

changes in government policy, including policies relating to common or directed clearing, and changes resulting from the adoption and implementation of the Dodd-Frank Act and any changes in the regulation of our industry with respect to speculative trading in commodity interests and derivative contracts;

•

the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others;

•

our ability to generate revenue from our market data that may be reduced or eliminated by the growth of electronic trading, the state of the overall economy or declines in subscriptions;

•

changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure;

•

the ability of our financial safeguards package to adequately protect us from the credit risks of clearing members;

•

the ability of our compliance and risk management methods to effectively monitor and manage our risks;

•

changes in price levels and volatility in the derivatives markets and in underlying fixed income, equity, foreign exchange and commodities markets;

•

economic, political and market conditions, including the recent volatility of the capital and credit markets and the impact of recent economic conditions on the trading activity of our current and potential customers;

•

our ability to accommodate increases in trading volume and order transaction traffic without failure or degradation of the performance of our systems;

•

our ability to execute our growth strategy and maintain our growth effectively;

•

our ability to manage the risks and control the costs associated with our acquisition, investment and alliance strategy;

•

our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business;

•

industry and customer consolidation;

•

decreases in trading and clearing activity;

•

the imposition of a transaction tax on futures and options on futures transactions and/or repeal of the 60/40 tax treatment of such transactions;

•

the unfavorable resolution of material legal proceedings; and

•

the seasonality of the futures business.

For a detailed discussion of these and other factors that might affect our performance, see Item 1A. of this Report, Item 1A. of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on February 26, 2010, and Item 1A. of our Quarterly Report on Form 10-Q, filed with the SEC on August 6, 2010.

ITEM 1.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	September 30, 2010			December 31, 2009
Assets
Current Assets:
Cash and cash equivalents	$	568.2		$	260.6
Marketable securities		44.3			42.6
Accounts receivable, net of allowance of $1.0 and $1.9		333.4			248.3
Other current assets		106.9			165.6
Cash performance bonds and security deposits		2,996.4			5,981.9

Total current assets		4,049.2			6,699.0
Property, net of accumulated depreciation and amortization of $572.0 and $546.1		740.6			738.5
Intangible assets – trading products		17,038.0			16,982.0
Intangible assets – other, net		3,470.5			3,246.5
Goodwill		7,961.0			7,549.2
Other assets		427.2			435.8

Total Assets	$	33,686.5		$	35,651.0


Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts payable	$	43.8		$	46.7
Short-term debt		420.5			299.8
Other current liabilities		205.5			195.2
Cash performance bonds and security deposits		2,996.4			5,981.9

Total current liabilities		3,666.2			6,523.6
Long-term debt		2,104.4			2,014.7
Deferred tax liabilities, net		7,769.9			7,645.9
Other liabilities		177.4			165.8

Total Liabilities		13,717.9			16,350.0


Redeemable non-controlling interest		67.8			—

Shareholders’ Equity:
Preferred stock, $0.01 par value, 9,860 shares authorized, none issued or outstanding		—			—
Series A junior participating preferred stock, $0.01 par value, 140 shares authorized, none issued or outstanding		—			—
Class A common stock, $0.01 par value, 1,000,000 shares authorized, 66,793 and 66,511 shares issued and outstanding as of September 30, 2010 and December 31, 2009		0.7			0.7
Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding		—			—
Additional paid-in capital		17,258.1			17,186.6
Retained earnings		2,766.8			2,239.9
Accumulated other comprehensive income (loss)		(124.8	)		(126.2	)

Total Shareholders’ Equity		19,900.8			19,301.0

Total Liabilities and Shareholders’ Equity	$	33,686.5		$	35,651.0

See accompanying notes to unaudited consolidated financial statements.

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	Quarter Ended September 30,						Nine Months Ended September 30,
	2010			2009			2010			2009
Revenues
Clearing and transaction fees	$	598.7		$	540.6		$	1,860.9		$	1,605.2
Market data and information services		101.4			81.4			291.0			249.0
Access and communication fees		11.3			11.4			33.4			34.5
Other		22.0			17.0			55.2			56.6

Total Revenues		733.4			650.4			2,240.5			1,945.3


Expenses
Compensation and benefits		110.4			87.3			312.3			262.0
Communications		9.8			11.5			30.8			35.5
Technology support services		12.5			11.3			37.4			34.7
Professional fees and outside services		26.1			17.9			82.5			61.9
Amortization of purchased intangibles		32.4			30.7			95.5			94.5
Depreciation and amortization		33.1			32.3			98.1			93.4
Occupancy and building operations		17.0			19.1			57.7			57.3
Licensing and other fee agreements		20.5			21.2			62.8			67.5
Restructuring		—			0.6			(0.5	)		5.2
Other		28.7			17.1			91.2			46.7

Total Expenses		290.5			249.0			867.8			758.7


Operating Income		442.9			401.4			1,372.7			1,186.6

Non-Operating Income (Expense)
Investment income		12.6			10.5			28.1			22.4
Impairment of long-term investment		—			(22.4	)		—			(22.4	)
Gains (losses) on derivative investments		—			—			6.0			—
Securities lending interest income		—			—			—			2.8
Securities lending interest and other costs		—			—			—			(0.1	)
Interest and other borrowing costs		(35.9	)		(32.1	)		(105.2	)		(103.2	)
Equity in losses of unconsolidated subsidiaries		(3.9	)		(1.6	)		(6.9	)		(4.5	)
Other income (expense)		—			—			—			(0.4	)

Total Non-Operating		(27.2	)		(45.6	)		(78.0	)		(105.4	)


Income before Income Taxes		415.7			355.8			1,294.7			1,081.2
Income tax provision		171.4			153.5			539.0			458.0

Net Income		244.3			202.3			755.7			623.2
Less: net income attributable to redeemable non-controlling interest		—			—			0.5			—

Net Income Attributable to CME Group	$	244.3		$	202.3		$	755.2		$	623.2


Earnings per Common Share Attributable to CME Group:
Basic	$	3.67		$	3.05		$	11.42		$	9.39
Diluted		3.66			3.04			11.39			9.37

Weighted Average Number of Common Shares:
Basic		66,556			66,384			66,125			66,339
Diluted		66,744			66,573			66,320			66,514

See accompanying notes to unaudited consolidated financial statements.

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	Class A Common Stock (Shares)			Class B Common Stock (Shares)		Common Stock and Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
Balance at December 31, 2009		66,511			3	$	17,187.3		$	2,239.9		$	(126.2	)	$	19,301.0
Comprehensive income:
Net income attributable to CME Group										755.2						755.2
Change in net unrealized loss on securities, net of tax of $0.9													(3.8	)		(3.8	)
Change in net actuarial loss on defined benefit plans, net of tax of $1.0													1.5			1.5
Change in net unrealized loss on derivatives, net of tax of $2.7													4.1			4.1
Change in foreign currency translation adjustment, net of tax of $0.2													(0.4	)		(0.4	)

Total comprehensive income attributable to CME Group																756.6
Cash dividends on common stock of $3.45 per share										(228.3	)					(228.3	)
Class A common stock issued to BM&FBOVESPA		2,206					607.1									607.1
Repurchase of Class A common stock		(2,007	)				(575.2	)								(575.2	)
Exercise of stock options		55					6.5									6.5
Excess tax benefits from option exercises and restricted stock vesting							3.6									3.6
Vesting of issued restricted Class A common stock		18					(1.4	)								(1.4	)
Shares issued to Board of Directors		8					2.3									2.3
Shares issued under Employee Stock Purchase Plan		2					0.7									0.7
Stock-based compensation							27.9									27.9

Balance at September 30, 2010		66,793			3	$	17,258.8		$	2,766.8		$	(124.8	)	$	19,900.8

See accompanying notes to unaudited consolidated financial statements.

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (continued)

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	Class A Common Stock (Shares)			Class B Common Stock (Shares)		Common Stock and Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
Balance at December 31, 2008		66,417			3	$	17,129.2		$	1,719.7		$	(160.3	)	$	18,688.6
Comprehensive income:
Net income attributable to CME Group										623.2						623.2
Change in net unrealized loss on securities, net of tax of $16.3													25.2			25.2
Change in net actuarial loss on defined benefit plans, net of tax of $0.9													(1.4	)		(1.4	)
Change in net unrealized loss on derivatives, net of tax of $2.8													4.4			4.4
Change in foreign currency translation adjustment, net of tax of $2.2													3.4			3.4

Total comprehensive income attributable to CME Group																654.8
Cash dividends on common stock of $3.45 per share										(229.0	)					(229.0	)
Repurchase of Class A common stock		(139	)				(27.0	)								(27.0	)
Exercise of stock options		92					16.8									16.8
Excess tax benefits from option exercises and restricted stock vesting							1.0									1.0
Vesting of issued restricted Class A common stock		16					(1.6	)								(1.6	)
Shares issued to Board of Directors		12					2.4									2.4
Shares issued under Employee Stock Purchase Plan		2					0.7									0.7
Stock-based compensation							23.6									23.6

Balance at September 30, 2009		66,400			3	$	17,145.1		$	2,113.9		$	(128.7	)	$	19,130.3

See accompanying notes to unaudited consolidated financial statements.

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)


	Nine Months Ended September 30,
	2010			2009
Cash Flows from Operating Activities
Net income	$	755.7		$	623.2
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation		27.9			23.6
Amortization of purchased intangibles		95.5			94.5
Depreciation and amortization		98.1			93.4
Credit Market Analysis Limited impairment		20.5			—
Net accretion of discounts and amortization of debt financing costs		3.8			11.6
Equity in losses of unconsolidated subsidiaries		6.9			4.5
Impairment of long-term investment		—			22.4
Deferred income taxes		(31.3	)		(28.9	)
Change in assets and liabilities:
Accounts receivable		(63.9	)		(30.2	)
Other current assets		15.0			(8.4	)
Other assets		4.8			(7.6	)
Accounts payable		(2.0	)		(34.9	)
Income taxes payable		(5.1	)		1.7
Other current liabilities		14.5			(56.2	)
Other liabilities		21.7			29.6
Other		0.9			(0.5	)

Net Cash Provided by Operating Activities		963.0			737.8


Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities		11.5			389.1
Purchases of available-for-sale marketable securities		(10.2	)		(159.9	)
Net change in NYMEX securities lending program investments		—			425.9
Purchases of property, net		(97.7	)		(112.9	)
Cash acquired in formation of Index Services		5.4			—
Proceeds from Chicago Board Options Exchange exercise right privileges		39.7			—
Purchase of Bolsa Mexicana de Valores, S.A.B. de C.V. shares		(17.4	)		—
Capital contributions to FXMarketSpace Limited		—			(2.8	)

Net Cash Provided by (Used in) Investing Activities		(68.7	)		539.4


Cash Flows from Financing Activities
Repayments of commercial paper, net of proceeds		(99.9	)		(1,168.8	)
Proceeds from other borrowings, net of issuance costs		608.0			743.5
Repayment of other borrowings		(300.0	)		(250.0	)
Net change in NYMEX securities lending program liabilities		—			(456.8	)
Cash dividends		(228.3	)		(229.0	)
Class A common stock issued to BM&FBOVESPA		607.1			—
Repurchase of Class A common stock, including costs		(575.2	)		(27.0	)
Proceeds from exercise of stock options		6.5			16.8
Distribution paid to non-controlling interest		(607.5	)		—

See accompanying notes to unaudited consolidated financial statements.

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(in millions)

(unaudited)


	Nine Months Ended September 30,
	2010			2009
Excess tax benefits related to employee option exercises and restricted stock vesting		3.6			1.2
Other		(1.0	)		(0.9	)

Net Cash Used in Financing Activities		(586.7	)		(1,371.0	)

Net change in cash and cash equivalents	$	307.6		$	(93.8	)
Cash and cash equivalents, beginning of period		260.6			297.9

Cash and Cash Equivalents, End of Period	$	568.2		$	204.1


Supplemental Disclosure of Cash Flow Information
Income taxes paid	$	572.6		$	469.6
Interest paid (excluding securities lending program)		103.3			88.2
Non-cash investing activities:
Change in net unrealized securities gains (losses)		4.7			41.5
Change in net unrealized derivatives gains (losses)		6.8			7.2

See accompanying notes to unaudited consolidated financial statements.

CME GROUP INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Presentation

The consolidated financial statements consist of CME Group Inc. (CME Group) and its subsidiaries (collectively, the company), including Chicago Mercantile Exchange Inc. (CME), the Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and their respective subsidiaries (collectively, the exchange). On March 18, 2010, CBOT acquired a 90% ownership interest in CME Group Index Services LLC (Index Services), a joint venture with Dow Jones & Company (Dow Jones). The financial statements and accompanying notes presented in this report include the financial results of Index Services beginning on March 19, 2010.

The accompanying interim consolidated financial statements have been prepared by CME Group without audit. Certain notes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. In the opinion of management, the accompanying consolidated financial statements include all normal recurring adjustments considered necessary to present fairly the financial position of the company at September 30, 2010 and December 31, 2009 and the results of operations and cash flows for the periods indicated. Quarterly results are not necessarily indicative of results for any subsequent period.

The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in CME Group’s Annual Report on Form 10-K for the year ended December 31, 2009, filed with the Securities and Exchange Commission (SEC) on February 26, 2010. Certain reclassifications have been made to the 2009 financial statements to conform to the presentation in 2010.

2. Business Combinations

On March 18, 2010, CBOT and Dow Jones entered into an agreement to form Index Services. Index Services was formed through the contribution of CBOT’s market data business and Dow Jones’ index business. Based on the preliminary fair value of assets contributed, the company has allocated $433.6 million to goodwill and $376.4 million to identifiable intangible assets. Intangible assets consist primarily of $232.8 million of customer relationships and $126.6 million of trade names.

In conjunction with its formation, Index Services issued $612.5 million of 4.40% fixed rate notes due 2018, which are guaranteed by CME Group, in an unregistered offering. Proceeds of $607.5 million were distributed to Dow Jones thereby reducing its interest in Index Services to 10%. Dow Jones retains the right to redeem its remaining interest at fair value on or after March 18, 2016. In addition, CBOT retains a right to call Dow Jones’ remaining interest at fair value on or after March 18, 2017. In accordance with current accounting guidance, Dow Jones’ interest has been classified as a redeemable non-controlling interest in the company’s consolidated financial statements.

The following summarizes the changes in redeemable non-controlling interest during the first nine months of 2010:


(in millions)
Balance at December 31, 2009	$	—
Contribution by Dow Jones		675.0
Distribution to Dow Jones		(607.5	)
Total comprehensive income attributable to redeemable non-controlling interest		0.3

Balance at September 30, 2010	$	67.8

The following summarizes total comprehensive income attributable to redeemable non-controlling interest:


(in millions)	Quarter Ended September 30, 2010			Nine Months Ended September 30, 2010
Net income for the period	$	—		$	0.5
Net unrealized loss on derivative related to 4.40% fixed rate notes		(0.1	)		(0.2	)

Total comprehensive income attributable to redeemable non-controlling interest	$	(0.1	)	$	0.3

3. Intangible Assets and Goodwill

Intangible assets consisted of the following at September 30, 2010 and December 31, 2009:


	September 30, 2010									December 31, 2009
(in millions)	Cost			Accumulated Amortization			Net Book Value			Cost			Accumulated Amortization			Net Book Value
Amortizable Intangible Assets:
Clearing firm, market data and other customer relationships	$	3,075.3		$	(265.2	)	$	2,810.1		$	2,842.5		$	(186.8	)	$	2,655.7
Lease-related intangibles		83.2			(30.6	)		52.6			83.2			(21.7	)		61.5
Dow Jones trading products (a)		—			—			—			74.0			(16.6	)		57.4
Technology-related intellectual property		38.9			(15.8	)		23.1			28.4			(10.3	)		18.1
Open interest		—			—			—			12.3			(12.3	)		—
Other (b)		14.9			(10.9	)		4.0			13.3			(8.5	)		4.8

		3,212.3			(322.5	)		2,889.8			3,053.7			(256.2	)		2,797.5

Foreign currency translation adjustments		(8.1	)		3.7			(4.4	)		(7.8	)		2.5			(5.3	)

Total Amortizable Intangible Assets	$	3,204.2		$	(318.8	)		2,885.4		$	3,045.9		$	(253.7	)		2,792.2

Indefinite-Lived Intangible Assets:
Trade names (c)								582.9									452.1
Other (d)								2.6									2.6
Foreign currency translation adjustments								(0.4	)								(0.4	)

Total intangible assets – other, net							$	3,470.5								$	3,246.5


Indefinite-lived trading products (a)							$	17,038.0								$	16,982.0

(a)	In connection with CBOT’s acquisition of 90% ownership in Index Services, the company now considers Dow Jones trading products to be indefinite-lived.

(b)	At September 30, 2010 and December 31, 2009, other amortizable intangible assets consisted of non-compete, service and market maker agreements.

(c)	In the second quarter of 2010, the company recorded a $0.7 million impairment charge to the Credit Market Analysis Limited (CMA) trade name as a result of its annual impairment testing.

(d)	At September 30, 2010 and December 31, 2009, other indefinite-lived intangible assets consisted of products in development.

Total amortization expense for intangible assets was $32.4 million and $30.7 million for the quarters ended September 30, 2010 and 2009, respectively. Total amortization expense for intangible assets was $95.5 million and $94.5 million for the first nine months of 2010 and 2009, respectively. As of September 30, 2010, the future estimated amortization expense related to amortizable intangible assets is expected to be:


(in millions)
Remainder of 2010	$	32.4
2011		128.1
2012		122.5
2013		116.3
2014		114.7
2015		111.0
Thereafter		2,260.4

Goodwill activity consisted of the following for the nine months ended September 30, 2010 and the year ended December 31, 2009:


(in millions)	Balance at December 31, 2009		Business Combination		Impairment Adjustment			Other Activity (e)			Balance at September 30, 2010
CBOT Holdings	$	5,035.7	$	—	$	—		$	—		$	5,035.7
NYMEX Holdings		2,463.1		—		—			(0.8	)		2,462.3
CMA		50.4		—		(19.8	)		(1.2	)		29.4
Index Services		—		433.6		—			—			433.6

Total Goodwill	$	7,549.2	$	433.6	$	(19.8	)	$	(2.0	)	$	7,961.0


(in millions)	Balance at December 31, 2008		Business Combination		Impairment Adjustment			Other Activity (e)			Balance at December 31, 2009
CBOT Holdings	$	5,036.1	$	—	$	—		$	(0.4	)	$	5,035.7
NYMEX Holdings		2,436.7		—		—			26.4			2,463.1
CMA		46.4		—		—			4.0			50.4

Total Goodwill	$	7,519.2	$	—	$	—		$	30.0		$	7,549.2

(e)

Other activity consisted primarily of adjustments to restructuring costs and tax contingencies for CBOT Holdings and NYMEX Holdings, the recognition of excess tax benefits upon exercise of stock options assumed for CBOT Holdings and NYMEX Holdings, and foreign currency translation adjustments for CMA.

The company conducts impairment testing of goodwill and indefinite-lived intangible assets at least annually. During the second quarter of 2010, the company recorded a $19.8 million impairment charge to reduce the carrying amount of CMA goodwill to its estimated fair value.

4. Debt

Debt consisted of the following:


(in millions)	September 30, 2010		December 31, 2009
Short-term debt:
$300.0 million floating rate notes due August 2010, interest equal to 3-month LIBOR plus 0.65%, reset quarterly⁽¹⁾	$	—	$	299.8
Term loan due 2011, interest equal to 3-month LIBOR plus 1.00%, reset quarterly⁽²⁾		420.5		—

Total short-term debt	$	420.5	$	299.8


Long-term debt:
Term loan due 2011, interest equal to 3-month LIBOR plus 1.00%, reset quarterly⁽²⁾	$	—	$	420.5
$750.0 million fixed rate notes due August 2013, interest equal to 5.40%		748.5		748.0
$750.0 million fixed rate notes due February 2014, interest equal to 5.75%		746.9		746.2
$612.5 million fixed rate notes due March 2018, interest equal to 4.40%⁽³⁾		609.0		—
Commercial paper⁽⁴⁾		—		100.0

Total long-term debt	$	2,104.4	$	2,014.7

(1)	In September 2008, the company entered into an interest-rate swap agreement that modified the variable interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.92% beginning with the interest accrued after November 6, 2008.

(2)	In September 2008, the company entered into an interest-rate swap agreement that modified the variable interest obligation associated with this facility so that the interest payable effectively became fixed at a rate of 4.72% beginning with the interest accrued after October 22, 2008.

(3)	In February 2010, the company entered into a forward-starting interest-rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 4.46% at issuance on March 18, 2010.

(4)	At December 31, 2009, this represented commercial paper backed by a three-year senior credit facility.

Commercial paper notes with an aggregate par value of $1.3 billion and maturities ranging from 2 to 61 days were issued during the nine months ended September 30, 2010. The weighted average discount rate for commercial paper outstanding at December 31, 2009 was 0.24%. There was no commercial paper outstanding at September 30, 2010. During the first nine months of 2010 and 2009, the weighted average balance, at par value, of commercial paper outstanding was $111.5 million and $677.4 million, respectively.

Long-term debt maturities, at par value, were as follows as of September 30, 2010:


(in millions)
2011	$	—
2012		—
2013		750.0
2014		750.0
2015		—
Thereafter		612.5

The fair value of the fixed rate notes due 2013 and 2014 was estimated using quoted market prices. The fair value of the fixed rate notes due 2018 was derived using a standard valuation model with market-based observable inputs including U.S. Treasury yields and interest rate spreads. At September 30, 2010, the fair values of the fixed rate notes by maturity date were as follows.


(in millions)	Fair Value
$750.0 million fixed rate notes due August 2013	$	840.9
$750.0 million fixed rate notes due February 2014		851.0
$612.5 million fixed rate notes due March 2018		653.3

5. Contingencies

Legal Matters. In October 2003, the U.S. Futures Exchange, L.L.C. (Eurex U.S.) and U.S. Exchange Holdings, Inc. filed suit against CBOT and CME in the United States District Court for the District of Columbia. The suit alleges that CBOT and CME violated the antitrust laws and tortuously interfered with the business relationship and contract between Eurex U.S. and The Clearing Corporation. Eurex U.S. and U.S. Exchange Holdings, Inc. are seeking treble damages. In April 2007, CME and CBOT filed two joint motions for summary judgment. In July 2010, the judge partially granted the company’s motion for summary judgment on the predatory pricing claims, finding no factual basis for such claims. Based on its investigation to date and advice from legal counsel, the company believes this suit is without merit and intends to defend itself vigorously against these charges.

In August 2008, Fifth Market filed a complaint against CME Group and CME seeking a permanent injunction against CME’s Globex system and enhanced damages for what the plaintiff alleges is willful infringement, in addition to costs, expenses and attorneys’ fees. The suit alleges that CME infringes two U.S. patents. Based on its investigation to date and advice from legal counsel, the company believes this suit is without merit and intends to defend itself vigorously against these charges.

In June 2009, CME and CBOT filed a complaint against Howard Garber seeking a declaratory judgment that neither CME nor CBOT was infringing certain of Mr. Garber’s patents and that one of his patents is invalid and unenforceable. In September 2009, Technology Research Group LLC, the current owner of one of the patents at issue, filed counterclaims alleging that CME and CBOT infringe, induce or contribute to the infringement and willfully infringe its patent.

Technology Research is seeking an injunction and damages no less than a reasonable royalty. Based on its investigation to date and advice from legal counsel, the company believes this suit is without merit and intends to defend itself vigorously against these charges.

In July 2009, Realtime Data LLC filed a complaint against CME Group and other exchanges alleging willful infringement of four patents which was later amended to add CBOT and NYMEX as defendants. Subsequently, two additional lawsuits have been filed each adding a claim for the infringement of an additional patent. One of lawsuits has been consolidated with the original action and the other is under consideration for consolidation. Based on its investigation to date and advice from legal counsel, the company believes this suit is without merit and intends to defend itself vigorously against these charges.

In addition, the company is a defendant in, and has potential for, various other legal proceedings arising from its regular business activities. While the ultimate results of such proceedings against the company cannot be predicted with certainty, the company believes that the resolution of any of these matters will not have a material adverse affect on its consolidated financial position or results of operations.

Intellectual Property Indemnifications. Certain agreements with customers and other third parties related to accessing the CME Globex platform, the CME ClearPort platform, and/or the Clearing 21 platform; utilizing market data services; licensing CME SPAN software; and calculating indexes as a service provider and licensing indexes as the basis of financial products may contain indemnifications from intellectual property claims that may be made against them as a result of their use of the applicable products and/or services. The potential future claims relating to these indemnifications cannot be estimated and, therefore, no liability has been recorded.

6. Guarantees

CME Clearing Contract Settlement. CME accounts for its guarantee of settlement of contracts in accordance with current accounting guidance on guarantees. CME marks-to-market all open positions at least twice a day, and requires payment from clearing firms whose positions have lost value and makes payments to clearing firms whose positions have gained value. In select circumstances where CME has introduced clearing services to newer markets, positions are marked-to-market daily, with the capability to mark-to-market more frequently as market conditions warrant. Under the extremely unlikely scenario of simultaneous default by every clearing firm who has open positions with unrealized losses, the maximum exposure related to CME’s guarantee would be equal to one half day of changes in fair value of all open positions, before considering CME’s ability to access defaulting clearing firms’ performance bond and security deposit balances as well as other available resources. During the first nine months of 2010, CME transferred an average of approximately $2.3 billion a day through its clearing system for settlement from clearing firms whose positions had lost value to clearing firms whose positions had gained value. CME reduces its guarantee exposure through initial and maintenance performance bond requirements and mandatory security deposits. The company believes that the guarantee liability in accordance with the accounting guidance is immaterial and therefore has not recorded any liability at September 30, 2010.

Mutual Offset Agreement. CME and Singapore Exchange Limited (SGX) have a mutual offset agreement with a current term through October 2010. The term of the agreement will automatically renew for a one-year period unless either party provides advance notice of their intent to terminate. CME can maintain collateral in the form of U.S. Treasury securities or irrevocable letters of credit. At September 30, 2010, CME was contingently liable to SGX on irrevocable letters of credit totaling $83.0 million. Regardless of the collateral, CME guarantees all cleared transactions submitted through SGX and would initiate procedures designed to satisfy these financial obligations in the event of a default, such as the use of performance bonds and security deposits of the defaulting clearing firm.

Cross-Margin Agreements. CME and Options Clearing Corporation (OCC) have a cross-margin arrangement, whereby a common clearing firm may maintain a cross-margin account in which the clearing firm’s positions in certain CME futures and options on futures contracts are combined with certain positions cleared by OCC for purposes of calculating performance bond requirements. The performance bond deposits are held jointly by CME and OCC. If a participating firm defaults, the gain or loss on the liquidation of the firm’s open position and the proceeds from the liquidation of the cross-margin account would be allocated 50% each to CME and OCC.

Cross-margin agreements exist with CME and Fixed Income Clearing Corp (FICC) whereby the clearing firms’ offsetting positions with CME are subject to reduced margin requirements. Clearing firms maintain separate performance bond deposits with each clearing house, but depending on the net offsetting positions between CME and FICC, each clearing

house may reduce the firm’s performance bond requirement. In the event of a firm default, the total liquidation net gain or loss on the firm’s offsetting open positions and the proceeds from the liquidation of the performance bond collateral held by each clearing house’s supporting offsetting positions would be divided evenly between CME and the applicable clearing house.

Additionally, for the FICC cross-margin agreements, if, after liquidation of all the positions and collateral of the defaulting firm at each respective clearing organization, and taking into account any cross-margining loss sharing payments, any of the participating clearing organizations has a remaining liquidating surplus, and any other participating clearing organization has a remaining liquidating deficit, any additional surplus from the liquidation would be shared with the other clearing houses to the extent that they have a remaining liquidating deficit. Any remaining surplus funds would be passed to the bankruptcy trustee.

GFX Corporation Letter of Credit. CME guarantees a $5.0 million standby letter of credit for GFX Corporation (GFX). The beneficiary of the letter of credit is the clearing firm that is used by GFX to execute and maintain its futures positions. Per exchange requirements, GFX is required to place performance bond deposits with its clearing firm. The letter of credit, utilized as performance bond, would be drawn on in the event that GFX defaults in meeting requirements to its clearing firm. In the unlikely event of a payment default by GFX, if GFX’s performance bond is not sufficient to cover the deficit, CME would guarantee the remaining deficit, if any.

7. Stock-Based Payments

Total expense for stock-based payments, including shares issued to the board of directors, converted CBOT Holdings options and converted NYMEX Holdings options, was $29.6 million and $25.5 million for the nine months ended September 30, 2010 and 2009, respectively. The total income tax benefit recognized in the consolidated statements of income for stock-based payment arrangements was $11.8 million and $10.2 million for the nine months ended September 30, 2010 and 2009, respectively.

In the first nine months of 2010, the company granted employees stock options totaling 277,604 shares under the CME Group Omnibus Stock Plan. The options have a ten-year term with exercise prices ranging from $271 to $314 per share, the closing market price on the dates of grant. The fair value of these options totaled $28.1 million, measured at the grant dates using the Black-Scholes valuation model, which is recognized as compensation expense on an accelerated basis over the vesting period of four years. The Black-Scholes fair values of the option grants were calculated using the following assumptions: dividend yield ranging from 1.5% to 1.7%; expected volatility ranging from 43% to 44%; risk-free interest rates ranging from 1.9% to 2.9% and an expected life of 6.2 years. The grant date weighted average fair value of options granted during the first nine months of 2010 was $101 per share.

In the first nine months of 2010, the company granted 130,063 shares of restricted Class A common stock and 428 restricted stock units which generally have a vesting period of two to four years. The fair value of these grants was $35.7 million, which is recognized as compensation expense on an accelerated basis over the vesting period. In the first nine months of 2010, the company granted 1,020 performance shares. The vesting of these shares is contingent on meeting stated goals over a performance period.

8. Fair Value Measurements

Accounting guidance on fair value measurements and related disclosures provides direction for using fair value to measure assets and liabilities by defining fair value and establishing a framework for measuring fair value. The guidance creates a three-level hierarchy that establishes classification of fair value measurements for disclosure purposes.

•

Level 1 inputs, which are considered the most reliable evidence of fair value, consist of quoted prices (unadjusted) for identical assets or liabilities in active markets.

•

Level 2 inputs consist of observable market data, other than level 1 inputs, such as quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are directly observable.

•

Level 3 inputs consist of unobservable inputs which are derived and cannot be corroborated by market data or other entity-specific inputs.

In general, the company uses quoted prices in active markets for identical assets to determine the fair value of marketable securities and equity investments. Level 1 assets generally include U.S. Treasury securities, exchange-traded

mutual funds and publicly-traded equity securities. If quoted prices are not available to determine fair value, the company uses other inputs that are observable either directly or indirectly. Assets included in level 2 generally consist of U.S. Government agency securities, municipal bonds, asset-backed securities and certain corporate bonds. There were no level 3 assets that were valued on a recurring basis as of September 30, 2010.

The company determined the fair value of its interest rate swap contracts, considered level 2 assets, using standard valuation models with market-based observable inputs including forward and spot exchange rates and interest rate curves. The level 2 marketable securities are measured at fair value based on matrix pricing based on prices of similar securities with similar inputs such as maturity dates, interest rates and credit ratings.

Financial assets and liabilities recorded in the consolidated balance sheet as of September 30, 2010 were classified in their entirety based on the lowest level of input that was significant to each asset or liability’s fair value measurement.

Financial Instruments Measured at Fair Value on a Recurring Basis:


	As of September 30, 2010
(in millions)	Level 1		Level 2		Level 3		Total
Assets at Fair Value:
Marketable securities:
U.S. Treasury securities	$	5.1	$	—	$	—	$	5.1
Mutual funds		26.3		—		—		26.3
Corporate bonds		—		0.1		—		0.1
Municipal bonds		—		4.7		—		4.7
Asset-backed securities		—		2.5		—		2.5
U.S. Government agency securities		—		5.6		—		5.6

Total		31.4		12.9		—		44.3
Equity investments		80.1		—		—		80.1

Total Assets at Fair Value	$	111.5	$	12.9	$	—	$	124.4

Liabilities at Fair Value:
Interest rate swap contracts	$	—	$	15.1	$	—	$	15.1

Total Liabilities at Fair Value	$	—	$	15.1	$	—	$	15.1

There were no transfers of assets or liabilities between level 1 and level 2 during the first nine months of 2010. There were also no assets or liabilities valued at fair value on a recurring basis using significant unobservable inputs during the first nine months of 2010.

During the second quarter of 2010, the company recorded impairment charges on goodwill and a trade name related to CMA. The fair values of CMA’s goodwill and trade name were derived using discounted cash flow models. As of the impairment test date, the fair values of CMA’s goodwill and trade name were $28.5 million and $0.9 million, respectively. During the third quarter of 2010, the company also recorded an impairment charge on its investment in OneChicago, LLC. At the impairment test date, the fair value of the investment was estimated to be zero based on a discounted cash flow analysis. All three assets were measured at fair value on a non-recurring basis utilizing level 3 inputs.

9. Earnings Per Common Share

Basic earnings per common share is computed by dividing net income by the weighted average number of shares of all classes of common stock outstanding for each reporting period. Diluted earnings per share reflects the increase in shares using the treasury stock method to reflect the impact of an equivalent number of shares of common stock if stock options were exercised and restricted stock awards were converted into common stock. Outstanding stock options and restricted stock awards of approximately 984,000 and 865,000 were anti-dilutive for the quarter and nine months ended September 30, 2010, respectively. Outstanding stock options and restricted stock awards of approximately 613,000 and 750,000 were anti-dilutive for the quarter and nine months ended September 30, 2009, respectively. These options and awards were not included in the diluted earnings per common share calculation.


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
(in millions, except shares and per share data)	2010		2009		2010		2009
Net Income Attributable to CME Group	$	244.3	$	202.3	$	755.2	$	623.2

Weighted Average Number of Common Shares (in thousands):
Basic		66,556		66,384		66,125		66,339
Effect of stock options		131		163		146		150
Effect of restricted stock awards		57		26		49		25

Diluted		66,744		66,573		66,320		66,514


Earnings per Common Share Attributable to CME Group:
Basic	$	3.67	$	3.05	$	11.42	$	9.39
Diluted		3.66		3.04		11.39		9.37

10. Subsequent Events

The company has evaluated subsequent events through the date the financial statements were issued. The company has determined that there were no subsequent events that require disclosure.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is provided as a supplement to, and should be read in conjunction with, the accompanying unaudited consolidated financial statements and notes in this Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2009.

References in this discussion and analysis to “we,” “us” and “our” are to CME Group Inc. (CME Group) and its consolidated subsidiaries, collectively. References to “exchange” are to Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), and New York Mercantile Exchange, Inc. (NYMEX), collectively.

RESULTS OF OPERATIONS

Financial Highlights

The following summarizes significant changes in our financial performance for the periods presented.


	Quarter Ended September 30,									Nine Months Ended September 30,
(dollars in millions, except per share data)	2010			2009			Change			2010			2009			Change
Total revenues	$	733.4		$	650.4			13	%	$	2,240.5		$	1,945.3			15	%
Total expenses		290.5			249.0			17			867.8			758.7			14
Operating margin		60	%		62	%					61	%		61	%
Non-operating income (expense)	$	(27.2	)	$	(45.6	)		(40	)	$	(78.0	)	$	(105.4	)		(26	)
Effective tax rate		41	%		43	%					42	%		42	%
Net income attributable to CME Group	$	244.3		$	202.3			21		$	755.2		$	623.2			21
Diluted earnings per common share attributable to CME Group		3.66			3.04			20			11.39			9.37			22
Cash flows from operating activities											963.0			737.8			31

•

An increase in clearing and transaction fees resulting from increased trading volume contributed to an increase in revenues in the third quarter and first nine months of 2010.

•

An increase in compensation and benefits expense due to addition of employees related to the formation of CME Group Index Services LLC (Index Services) as well bonus expense contributed to higher overall expenses in the third quarter and first nine months of 2010. A goodwill and trade name impairment charge related to our Credit Market Analysis Limited (CMA) operations also contributed to an increase in expenses in the first nine months of 2010.

•

In the third quarter of 2009, we recognized an impairment loss on our investment in IMAREX ASA (IMAREX), resulting in a decrease in non-operating income (expense) in the third quarter and first nine months of 2010.

•

The decline in the effective tax rate was largely attributable to an additional valuation allowance recognized in 2009 related to an impairment charge on our investment in IMAREX.

•

Cash flows from operations are strongly correlated with trading volume. Average daily volume increased by 19% during the first nine months of 2010 when compared with the same period in 2009.

Revenues


	Quarter Ended September 30,							Nine Months Ended September 30,
(dollars in millions)	2010		2009		Change			2010		2009		Change
Clearing and transaction fees	$	598.7	$	540.6		11	%	$	1,860.9	$	1,605.2		16	%
Market data and information services		101.4		81.4		25			291.0		249.0		17
Access and communication fees		11.3		11.4		(1	)		33.4		34.5		(3	)
Other		22.0		17.0		30			55.2		56.6		(2	)

Total Revenues	$	733.4	$	650.4		13		$	2,240.5	$	1,945.3		15

Clearing and Transaction Fees

Based on total volume and average rate per contract data below, we estimate that clearing and transaction fees revenue increased by $73.6 million during the third quarter due to the increase in total volume partially offset by a decline of $15.5 million due to the decrease in average rate per contract, resulting in a net increase in revenues in the third quarter of 2010 of $58.1 million when compared with the same period in 2009.

During the first nine months of 2010, we estimate that clearing and transaction fees revenue increased by $306.0 million due to the increase in total volume when compared with the same period in 2009. This increase was partially offset by a decline in revenue of $50.3 million due to the decrease in average rate per contract, resulting in a net increase in revenues in the first nine months of 2010 of $255.7 million when compared with the same period in 2009.

Average rate per contract is impacted by our rate structure, which includes volume-based incentives; product mix; trading venue, and the percentage of trading volume executed by customers who are members compared with non-member customers. Due to the relationship between average rate per contract and volume, the change in revenues attributable to changes in each is only an approximation.


	Quarter Ended September 30,							Nine Months Ended September 30,
	2010		2009		Change			2010		2009		Change
Total volume (in millions)		739.2		648.4		14	%		2,309.0		1,929.4		20	%
Clearing and transaction fees (in millions)	$	598.7	$	540.6		11		$	1,860.9	$	1,605.2		16
Average rate per contract		0.810		0.834		(3	)		0.806		0.832		(3	)

Trading Volume

The following table summarizes average daily trading volume.


	Quarter Ended September 30,									Nine Months Ended September 30,
(amounts in thousands)	2010			2009			Change			2010			2009			Change
Average Daily Volume by Product Line:
Interest rate		5,020			4,422			14	%		5,409			4,223			28	%
Equity		2,809			2,656			6			3,030			3,053			(1	)
Foreign exchange		866			661			31			930			580			60
Agricultural commodity		941			708			33			862			738			17
Energy		1,657			1,483			12			1,689			1,467			15
Metal		257			201			28			297			202			47

Aggregate average daily volume		11,550			10,131			14			12,217			10,263			19

Average Daily Volume by Venue:
Electronic		9,574			8,267			16			10,168			8,253			23
Open outcry		1,327			1,261			5			1,396			1,343			4
Privately negotiated		181			150			21			190			162			17

Total exchange-traded volume		11,082			9,678			15			11,754			9,758			20
Total CME ClearPort		468			453			3			463			505			(8	)

Aggregate average daily volume		11,550			10,131			14			12,217			10,263			19

Electronic Volume as a Percentage of Total Volume		83	%		82	%					83	%		80	%

Interest Rate Products

The following table summarizes average daily volume for our key interest rate products.


	Quarter Ended September 30,							Nine Months Ended September 30,
(amounts in thousands)	2010		2009		Change			2010		2009		Change
Eurodollar futures		1,639		1,815		(10	)%		1,977		1,743		13	%
Eurodollar options		646		645		—			733		655		12
U.S. Treasury futures and options:
10-Year		1,470		938		57			1,370		893		53
5-Year		533		441		21			537		399		35
30-Year		402		299		34			385		287		34
2-Year		229		216		6			292		178		64

The overall improvement in the economic environment in 2010 following the credit crisis contributed to the increase in interest rate product volume in the first nine months of 2010 compared with the same period in 2009. The improving macroeconomic conditions led to changing expectations of U.S. Treasury rates as well as increased market participants’ use of these products, which contributed to an increase in volume.

During the third quarter of 2010, the overall increase in volume was primarily due to changing market expectations about interest rate increases based on a continued zero interest rate policy in the United States. The market now believes that increases in short-term U.S. interest rates are less likely to occur in the near future. This shift in expectations has led to an increase in volume for longer-term U.S. Treasury products and a decrease in volume for short-term Eurodollar products in the third quarter of 2010 when compared with the same period of 2009. There was also strong growth in Treasury options, as customers increased their trading volumes particularly in the 10-year and 30-year Treasury products.

Equity Products

The following table summarizes average daily volume for our key equity products.


	Quarter Ended September 30,							Nine Months Ended September 30,
(amounts in thousands)	2010		2009		Change			2010		2009		Change
E-mini S&P futures and options		2,190		2,066		6	%		2,392		2,396		—	%
E-mini NASDAQ futures and options		328		300		9			335		319		5

We believe the increase in equity product volume for the third quarter of 2010 when compared with the same period in 2009 is attributable to an improved economic outlook. Equity volume has decreased in the third quarter 2010 when compared with the first six months of 2010 largely due to high periods of volatility during the second quarter of 2010.

Foreign Exchange Products

We believe that the increase in volume is attributable to the weakening of the U.S. dollar compared with other major foreign currencies due to the extended zero interest rate policy. This has resulted in increased volatility with other major foreign currencies, which contributed to increased trading activity. In addition, our cross-sell efforts to market participants in other asset classes contributed to growth in volume. The increase in euro products largely contributed to the increase in volume. Euro product volume increased by 46% and 72% to an average of 0.3 million and 0.4 million contracts per day in the third quarter and first nine months of 2010, respectively.

Agricultural Commodity Products

We believe that the increase in average daily volume for commodity products in the third quarter of 2010 and the first nine months of 2010 when compared with the same periods in 2009 was attributable to increased volatility associated with changes in global supply and demand.

Energy Products

The following table summarizes average daily volume for our key energy products.


	Quarter Ended September 30,							Nine Months Ended September 30,
(amounts in thousands)	2010		2009		Change			2010		2009		Change
Crude oil futures and options		831		731		14	%		869		699		24	%
Natural gas futures and options		501		481		4			489		472		3

We believe the increase in average daily volume in the third quarter and first nine months of 2010 when compared with the same periods in 2009 was primarily attributable to improving macroeconomic conditions.

Metal Products

We believe that the increase in metal product volume in 2010 was attributable to increased investment in precious metals as an asset class during periods of uncertainty in interest rates and foreign exchange.

Average Rate per Contract

The average rate per contract decreased in the third quarter and first nine months of 2010 when compared with the same periods in 2009 due to an increase in member trading volume, which increased faster than non-member trading in the third quarter and first nine months of 2010. In addition, the average rate per contract decreased in the third quarter of 2010 when compared with the same period in the prior year due to higher tier discounts.

Concentration of Revenue

We bill a substantial portion of our clearing and transaction fees to our clearing firms. The majority of clearing and transaction fees received from clearing firms represent charges for trades executed and cleared on behalf of their customers. As of September 30, 2010, we had approximately 70 active clearing firms. One firm represented 11% of our clearing and transaction fees revenue in the first nine months of 2010. No other firm represented more than 10% of our clearing and transaction fees revenue in the first nine months of 2010. Should a clearing firm withdraw, we believe that the customer portion of the firm’s trading activity would likely transfer to another clearing firm of the exchange. Therefore, we do not believe we are exposed to significant risk from the loss of revenue received from a particular clearing firm.

Other Sources of Revenue

Beginning March 19, 2010, market data and information services revenue includes market data and licensing revenue from Index Services. The increase in revenue was primarily attributable to Index Services.

The increase in market data and information services revenue during the third quarter and first nine months of 2010 was also attributable to an increase in the basic device monthly fee. The increase was offset by the decrease in basic device counts due primarily to cost-cutting initiatives at customer firms.


	Quarter Ended September 30,							Nine Months Ended September 30,
(dollars in millions, except monthly fee per device)	2010		2009		Change			2010		2009		Change
Average estimated monthly basic device screen count		384,000		401,000		(17,000	)		385,000		415,000		(30,000	)
Basic device monthly fee per device	$	61	$	55	$	6		$	61	$	55	$	6
Estimated increase (decrease) in revenues
Due to an increase in monthly fee per device					$	6.9						$	20.8
Due to a decrease in screen counts						(2.7	)						(14.8	)

The two largest resellers of our market data represented approximately 46% of our market data and information services revenue in the first nine months of 2010. Despite this concentration, we consider exposure to significant risk of revenue loss to be minimal. In the event that one of these vendors no longer subscribes to our market data, we believe the majority of that vendor’s customers would likely subscribe to our market data through another reseller. Additionally, several of our largest institutional customers that utilize services from our two largest resellers report usage and remit payment of quotation data fees directly to us.

During the third quarter of 2010 when compared with the same period in 2009, other revenues increased primarily due to $5.1 million of revenue generated through our agreement with BM&FBOVESPA S.A. (BM&FBOVESPA) to develop a new multi-asset class electronic trading platform. During the first nine months of 2010 when compared with the same period in 2009, a decline in trading revenues generated by GFX Corporation (GFX) of $6.6 million resulting from lower trading activity and narrower trading margins contributed to the decrease in other revenues. The decline in the first nine months of 2010 was partially offset by an increase in revenue attributable to the BM&FBOVESPA agreement of $5.6 million.

Expenses


	Quarter Ended September 30,							Nine Months Ended September 30,
(dollars in millions)	2010		2009		Change			2010			2009		Change
Compensation and benefits	$	110.4	$	87.3		27	%	$	312.3		$	262.0		19	%
Communications		9.8		11.5		(15	)		30.8			35.5		(13	)
Technology support services		12.5		11.3		11			37.4			34.7		8
Professional fees and outside services		26.1		17.9		46			82.5			61.9		33
Amortization of purchased intangibles		32.4		30.7		5			95.5			94.5		1
Depreciation and amortization		33.1		32.3		3			98.1			93.4		5
Occupancy and building operations		17.0		19.1		(11	)		57.7			57.3		1
Licensing and other fee agreements		20.5		21.2		(3	)		62.8			67.5		(7	)
Restructuring		—		0.6		(105	)		(0.5	)		5.2		(109	)
Other		28.7		17.1		68			91.2			46.7		95

Total Expenses	$	290.5	$	249.0		17		$	867.8		$	758.7		14

Operating expenses increased by $41.5 million and $109.1 million in the third quarter and first nine months of 2010, respectively, when compared with the same periods in 2009. The following table shows the estimated impact of key factors resulting in the increase (decrease) in operating expenses.


	Quarter Ended September 30, 2010					Nine Months Ended September 30, 2010
(dollars in millions)	Amount of Change		Change as a Percentage of Total Expenses			Amount of Change		Change as a Percentage of Total Expenses
Salaries, benefits and employer taxes	$	10.7		4	%	$	26.2		3	%
Bonus expense		10.4		4			22.4		3
CMA goodwill and trade name impairment		—		—			20.5		3
Professional fees related to Index Services		1.4		1			13.8		2
Marketing and travel expense		4.0		2			10.7		1
Customer and legal accruals		7.0		3			7.8		1
Other expenses, net		8.0		3			7.7		1

Total	$	41.5		17	%	$	109.1		14	%

An increase in average headcount primarily due to Index Services as well as salary increases and rising healthcare costs contributed to the rise in salaries, benefits and employer taxes.

The increase in our bonus expense in the third quarter and first nine months of 2010 was due to improved performance relative to our 2010 cash earnings target compared with 2009 relative to our 2009 cash earnings target.

Impairment charges on goodwill and trade name related to our CMA operations in the second quarter of 2010 led to an increase in other expenses in the first nine months of 2010.

Costs incurred for Index Services led to an increase in professional fee expenses in the first nine months of 2010 when compared with the same period in 2009. This increase included $10.3 million of professional and legal fees incurred for the formation of Index Services.

Global expansion and establishment of strategic partnerships contributed to an increase in marketing and travel expenses in the third quarter and first nine months of 2010.

Expenses increased in the third quarter and first nine months of 2010 due to additional customer settlements and additional accruals for various legal matters.

Non-Operating Income (Expense)


	Quarter Ended September 30,									Nine Months Ended September 30,
(dollars in millions)	2010			2009			Change			2010			2009			Change
Investment Income	$	12.6		$	10.5			18	%	$	28.1		$	22.4			25	%
Impairment of long-term investment		—			(22.4	)		(100	)		—			(22.4	)		(100	)
Gains (losses) on derivative investments		—			—			—			6.0			—			n.m.
Securities lending interest income		—			—			—			—			2.8			(100	)
Securities lending interest and other costs		—			—			—			—			(0.1	)		(100	)
Interest and other borrowing costs		(35.9	)		(32.1	)		12			(105.2	)		(103.2	)		2
Equity in losses of unconsolidated subsidiaries		(3.9	)		(1.6	)		133			(6.9	)		(4.5	)		51
Other income (expense)		—			—			—			—			(0.4	)		(100	)

Total Non-Operating	$	(27.2	)	$	(45.6	)		(40	)	$	(78.0	)	$	(105.4	)		(26	)

n.m. not meaningful

The increase in investment income during the first nine months of 2010 when compared with the same periods in 2009 was largely attributable to a $13.0 million increase in dividend income from our investments in BM&FBOVESPA, TMX Group Inc. and Bolsa Mexicana de Valores, S.A.B. de C.V. The increase was partially offset by a $4.1 million decrease in interest income as a result of lower average investment balances. In addition, gains on marketable securities related to our non-qualified deferred compensation plans declined by $3.2 million. Gains and losses from these non-qualified deferred compensation plan securities are offset by an equal amount of compensation and benefits expense. During the third quarter of 2010 when compared with the same period in 2009, investment income increased largely due to an increase in dividend income from our investment in BM&FBOVESPA.

As of September 30, 2009, we determined that our investment in IMAREX was impaired due to an extended and significant decline in the market price of its stock. As a result, we recognized an impairment charge of $22.4 million in the third quarter of 2009.

In March 2010, we recognized a $6.0 million gain on derivative investments as a result of a settlement from the Lehman Brothers bankruptcy proceedings. The settlement related to an unsecured claim tied to a derivative contract that we terminated in September 2008 when Lehman Brothers filed for bankruptcy.

On March 18, 2010, we issued $612.5 million of 4.40% fixed rate notes due 2018, resulting in an increase in average effective yield and total cost of borrowing.


	Quarter Ended September 30,									Nine Months Ended September 30,
	2010			2009			Change			2010			2009			Change
Weighted average borrowings outstanding (in millions)	$	2,653.7		$	2,640.6		$	13.1		$	2,713.6		$	2,987.2		$	(273.6	)
Weighted average effective yield		5.08	%		4.51	%		0.57	%		4.90	%		4.08	%		0.82	%
Total cost of borrowing (1)		5.39			4.80			0.59			5.18			4.68			0.50

(1)	Total cost of borrowing includes interest, commitment fees, discount accretion and debt issuance costs.

The increase in equity in losses of unconsolidated subsidiaries in the third quarter and first nine months of 2010 when compared with the same periods in 2009 is largely attributable to the $2.2 million impairment charge on our investment in OneChicago, LLC.

Income Tax Provision

The following table summarizes the effective tax rate for the periods presented:


	2010			2009			Change
Quarter ended September 30		41.2	%		43.1	%		(1.9	)%
Nine months ended September 30		41.6			42.4			(0.8	)

The decrease in the effective tax rate in the third quarter of 2010 and first nine months of 2010 when compared with the same periods of 2009 is largely attributable to an additional valuation allowance of $5.8 million recognized in 2009 related to an impairment charge on our investment in IMAREX.

In addition to the additional valuation allowance recorded on our investment in IMAREX, the decrease in the effective tax rate for the first nine months of 2010 was also due to a $6.4 million reduction in the liability for uncertain tax positions recorded in the first quarter of 2010. The decrease in the effective tax rate in the first nine months of 2010 was partially offset by an increase resulting from the establishment of a valuation allowance for the tax benefit associated with CMA’s goodwill and trade name impairment in the second quarter of 2010.

Liquidity and Capital Resources

Sources and Uses of Cash. Net cash provided by operating activities was $963.0 million for the first nine months of 2010 compared with $737.8 million for the same period in 2009. The increase in net cash provided by operating activities was due primarily to higher trading volumes and increased profitability. In the first nine months of 2010, net cash provided by operating activities was $207.3 million higher than net income. This increase was primarily the result of depreciation and amortization expense of $98.1 million and amortization of purchased intangibles of $95.5 million. The increase was offset by an increase in accounts receivable of $63.9 million. Accounts receivable in any period result primarily from the clearing and transaction fees billed in the last month of the reporting period.

Cash used in investing activities was $68.7 million in the first nine months of 2010 compared with cash provided by investing activities of $539.4 million in the first nine months of 2009. The increase in cash used was largely attributable to the termination of the NYMEX securities lending program in 2009 as well as the decrease in proceeds from marketable securities, net of purchases, of $227.9 million.

Cash used in financing activities was $586.7 million in the first nine months of 2010 compared with $1.4 billion for the same period in 2009. The decrease in cash used was primarily attributable to a decrease in commercial paper repayments, net of proceeds, proceeds from our share issuance to BM&FBOVESPA as well as the termination of the NYMEX securities lending program in 2009. The decrease was partially offset by the distribution to Dow Jones of $607.5 million related to Index Services as well as an increase in share repurchases of $548.2 million. Share repurchases increased in an effort to offset most of the dilution associated with the issuance of shares to BM&FBOVESPA.

Debt Instruments. The following table summarizes our debt outstanding as of September 30, 2010:


(in millions)	Par Value
Term loan due 2011, interest equal to 3-month LIBOR plus 1.00%⁽¹⁾	$	420.5
Fixed rate notes due August 2013, interest equal to 5.40%		750.0
Fixed rate notes due February 2014, interest equal to 5.75%		750.0
Fixed rate notes due March 2018, interest equal to 4.40%⁽²⁾		612.5

(1)	In September 2008, the company entered into an interest-rate swap agreement that modified the variable interest obligation associated with this loan so that the interest payable effectively became fixed at a rate of 4.72% beginning with the interest accrued after October 22, 2008.

(2)

In March 2010, we completed an unregistered offering of fixed rate notes due 2018. Net proceeds from the offering were used to fund a distribution to Dow Jones in conjunction with our investment in Index Services. In February 2010, the company entered into a forward-starting interest-rate swap agreement that modified the

interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 4.46% beginning with the interest accrued after March 18, 2010.

We maintain a $1.4 billion senior credit facility with various financial institutions, including the $420.5 million term loan and a $945.5 million revolving credit facility. As long as we are not in default under the senior credit facility, we have the option to increase the facility from time to time by an aggregate amount of up to $1.1 billion, to a total of $2.5 billion, with the consent of the agent and the lenders providing the additional funds. The revolving credit facility expires on August 21, 2011. Any commercial paper outstanding would be backed by this revolving credit facility.

At September 30, 2010, we have excess borrowing capacity for general corporate purposes of approximately $945.5 million.

We maintain a 364-day revolving line of credit with a consortium of banks to be used in certain situations by our clearing house. The line of credit provides for borrowings of up to $1.0 billion. This line of credit is collateralized by clearing firm security deposits held by us in the form of U.S. Treasury or agency securities, as well as security deposit funds in the Interest Earnings Facility and any performance bond deposits of a clearing firm that may default on its obligation. The line of credit can only be drawn on to the extent that it is collateralized. At September 30, 2010, security deposit collateral available was $2.2 billion. We have the option to request an increase in the line from $1.0 billion to $1.5 billion.

The indentures governing our floating and fixed rate notes, our 364-day revolving line of credit for $1.0 billion and our senior credit facility for $1.4 billion do not contain specific covenants that restrict the ability to pay dividends. These agreements, however, do contain other customary financial and operating covenants that place restrictions on the operations of the company, which could indirectly affect the ability to pay dividends.

Under our senior credit facility, we are required to maintain a consolidated net worth of at least $12.1 billion.

In addition, our 364-day revolving line of credit contains a requirement that CME remain in compliance with a consolidated tangible net worth test, defined as CME consolidated shareholder’s equity less intangible assets (as defined in the agreement), of not less than $125.0 million. In the event that CME elects to increase the facility, the minimum consolidated tangible net worth test will increase ratably up to $187.5 million.

As of September 30, 2010, we are in compliance with the various covenant requirements of all our debt facilities.

CME Group, as a holding company, has no operations of its own. Instead, it relies on dividends declared and paid to it by its subsidiaries in order to provide a portion of the funds which it uses to pay dividends to its shareholders.

To satisfy our performance bond obligation with Singapore Exchange Limited, we may pledge CME-owned U.S. Treasury securities in lieu of, or in combination with, irrevocable letters of credit. At September 30, 2010, the letters of credit totaled $83.0 million. CME also guarantees a $5.0 million standby letter of credit for GFX. The beneficiary of this letter of credit is the clearing firm that is used by GFX to execute and maintain its futures position. The letter of credit would be utilized in the event that GFX defaults in meeting performance bond requirements to its clearing firm.

The following table summarizes our credit ratings as of September 30, 2010:


Rating Agency	Short-Term Debt Rating	Long-Term Debt Rating	Outlook
Standard & Poor’s	A1+	AA	Stable
Moody’s Investors Service	P1	Aa3	Stable

Given our ability to pay down debt levels and refinance existing debt facilities if necessary, we expect to maintain an investment grade rating. If our ratings are downgraded due to a change in control which results in a downgrade below investment grade, we are required to make an offer to repurchase our fixed and floating rate notes at a price equal to 101% of the principal amount, plus accrued and unpaid interest.

Liquidity and Cash Management. Cash and cash equivalents totaled $568.2 million at September 30, 2010 and $260.6 million at December 31, 2009. The balance retained in cash and cash equivalents is a function of anticipated or possible short-term cash needs, prevailing interest rates, our investment policy and alternative investment choices. A majority of

our cash and cash equivalents balance is invested in money market mutual funds that invest only in U.S Treasury securities or U.S. government agency securities. Our exposure to risk is minimal given the nature of the investments.

On November 3, 2010, CME Group’s board of directors declared a regular quarterly dividend of $1.15 per share payable on December 27, 2010 to the shareholders of record as of December 10, 2010.

Net current deferred tax assets of $25.4 million and $23.8 million were included in other current assets at September 30, 2010 and December 31, 2009, respectively. Total net current deferred tax assets included primarily unrealized losses and accrued expenses.

Net long-term deferred tax liabilities were $7.8 billion and $7.6 billion at September 30, 2010 and December 31, 2009, respectively. Net deferred tax liabilities are primarily the result of purchase accounting for intangible assets in our mergers with CBOT Holdings and NYMEX Holdings.

We have a long-term deferred tax asset of $145.9 million included within our domestic long-term deferred tax liability. This deferred tax asset is for an unrealized capital loss incurred in Brazil related to our investment in BM&FBOVESPA. As of September 30, 2010, we do not believe that we currently meet the more-likely-than-not threshold that would allow us to fully realize the value of the unrealized capital loss. As a result, a partial valuation allowance of $64.5 million has been provided for the amount of the unrealized capital loss that exceeds potential capital gains that could be used to offset the capital loss in future periods. We also have a long-term deferred tax asset related to Brazilian taxes of $125.3 million for an unrealized capital loss incurred in Brazil related to our investment in BM&FBOVESPA. A full valuation allowance of $125.3 million has been provided because we do not believe that we currently meet the more-likely-than-not threshold that would allow us to realize the value of the unrealized capital loss in Brazil in the future. Valuation allowances of $60.9 million have also been provided for additional unrealized capital losses on various other investments.

Net long-term deferred tax assets also include a $25.2 million deferred tax asset for foreign net operating losses related to Swapstream. Our assessment at September 30, 2010 was that we did not currently meet the more-likely-than-not threshold that would allow us to realize the value of acquired and accumulated foreign net operating losses in the future. As a result, the $25.2 million deferred tax asset arising from these net operating losses has been fully reserved.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are subject to various market risks, including those caused by changes in interest rates, credit, foreign currency exchange rates and equity prices. There have not been material changes in our exposure to market risk since December 31, 2009. Refer to Item 7A. of CME Group’s Annual Report on Form 10-K for the year ended December 31, 2009 for additional information.

Item 4.

Controls and Procedures

(a) Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures are effective.

b) Changes in Internal Control Over Financial Reporting. As required by Rule 13a-15(d) under the Exchange Act, the company’s management, including the company’s Chief Executive Officer and Chief Financial Officer, have evaluated the company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to determine whether any changes occurred during the quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting. There were no changes in the company’s internal control over financial reporting during the period covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

There have been no material updates to the Legal Proceedings as set forth in Item 1. of our Annual Report on Form 10-K, filed with the SEC on February 26, 2010, and our Quarterly Report on Form 10-Q, filed with the SEC on August 6, 2010.

Item 1A.

Risk Factors

There have been no material updates to the Risk Factors as set forth in Item 1A. of our Annual Report on Form 10-K, filed with the SEC on February 26, 2010, and Item 1A. of our Quarterly Report on Form 10-Q, filed with the SEC on August 6, 2010. In addition to the other information contained in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in our Annual Report on Form 10-K and in our Quarterly Report on Form 10-Q for the period ended June 30, 2010, which are the risks that we believe are material at this time. These risks could materially and adversely affect our business, financial condition and results of operations. These risks and uncertainties are not the only ones facing us. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business in the future.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

(a)

Unregistered Sales of Equity Securities

On June 22, 2010, CME Group and BM&FBOVESPA entered into a definitive Share Purchase and Investor Rights Agreement providing for, among other things, BM&FBOVESPA’s increase in its ownership interest in CME Group to approximately 5% as previously announced in February 2010 as part of the expansion of their existing strategic partnership. Pursuant to the agreement, on July 16, 2010, CME Group issued to BM&FBOVESPA 2,206,478 shares of its Class A common stock, par value $0.01 per share, at a purchase price per share of $275.12 in cash, or approximately $607 million in the aggregate. The Class A Common Stock was issued and sold in reliance on the exemption from the registration provisions of the Securities Act of 1933 set forth in Section 4(2) thereof.

(c)

Issuer Purchases of Equity Securities


Period	(a) Total Number of Class A Shares Purchased (1)		(b) Average Price Paid Per Share		(c) Total Number of Class A Shares Purchased as Part of Publicly Announced Plans or Programs		(d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs(2)

July 1 to July 31		1,024,894	$	272.31		1,024,894		343,235

August 1 to August 31		—	$	—		—		343,235

September 1 to September 30		4,914	$	271.49		—		343,235

Total		1,029,808	$	272.30		1,024,894

(1)

Shares purchased consist of an aggregate of 4,914 shares of Class A common stock surrendered in the third quarter of 2010 to satisfy employees’ tax obligations upon the vesting of restricted stock and an aggregate of 1,024,894 shares of Class A common stock purchased under our publicly announced share repurchase program as described below.

(2)	Under the terms of the share buyback program announced on February 12, 2010, the company is authorized to purchase shares of Class A common stock up to 2.35 million shares. The authorization of the buyback was approved

in connection with our agreement to issue additional Class A common shares to BM&FBOVESPA to increase its aggregate share ownership in the company to 5% and serves to offset the dilution of the shares issued to BM&FBOVESPA.

Item 6.

Exhibits


31.1		Section 302 Certification—Craig S. Donohue

31.2		Section 302 Certification—James E. Parisi

32.1		Section 906 Certification

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (do not check if a smaller reporting company)

Smaller reporting company